Home>>News>>Yashoda Hospitals Malakpet Launches ‘Artificial Intelligence’ Integrated PET-CT Scan

Yashoda Hospitals Malakpet Launches ‘Artificial Intelligence’ Integrated PET-CT Scan

Hon’ble T. Harish Rao, Minister of Health & Family Welfare, Government of Telangana State, inaugurated the cutting-edge technology.

Yashoda Hospitals Malakpet’s Oncology Institute has launched an advanced ‘Artificial Intelligence’ integrated PET-CT for cancer detection. Hon’ble T. Harish Rao, Minister of Health & Family Welfare, Government of Telangana State, inaugurated the cutting-edge technology.

Yashoda Hospitals, one of the leading health care facilities in Hyderabad and the states of Telangana and Andhra Pradesh, is known for providing state-of-the-art medical care with top-notch technologies on par with the rest of the world.

Yashoda Oncology Institute has been providing the best cancer care to patients using cutting-edge technology. This new cutting-edge artificial intelligence integrated PET CT scanner at Yashoda Oncology Institute in Malakpet is another step toward early cancer detection.

“Due to advanced technology known as “Time of Flight,” the new scanner is now four times faster than previous generations’ scanners. The scanner produces high-quality images while taking less time to scan and emitting less radiation. This world-class PET-CT is very useful to Hyderabad and its people who live in the city’s eastern part,” said Shri Harish Rao, Minister of Health and Family Welfare, Government of Telangana.

Yashoda Hospitals has a comprehensive Nuclear Medicine department that offers services such as PET/CT, gamma camera imaging, and radionuclide therapy all under one roof. Integrating PET/CT into the multidisciplinary management of cancer patients allows for staging evaluation, assessment of response to therapy after treatment, and confirmation of remission.

Yashoda Hospitals’ Oncology Institute now offers advanced treatment with PRRT (Peptide receptor radionuclide therapy) for a few cancers such as prostate and neuroendocrine with the addition of a PET (CT) and nuclear medicine department. The hospital was the first in the city to offer advanced and rare imaging such as Ga -68 DOTA, Ga 68 PSMA, 18F DOPA PET/CTs, DAT imaging, and WBC scans.

“Yashoda Hospitals’ Oncology Institute is one of the busiest and most active centers, providing medical, surgical, and radionuclide therapies for the treatment of thyroid, neuroendocrine tumors, and prostate cancer. Patients come to us for treatment not only from Telangana and Andhra Pradesh but from all over India,” said Dr. G. S. Rao, Managing Director of the Yashoda Group of Hospitals.

“The Oncology Institute of Yashoda Hospitals – Malakpet has been well equipped with state-of-the-art facilities, and the launch of the AI integrated PET- CT for early detection of cancer would be the latest among the technology to provide the best care to the patients of the eastern part of the city,” said Dr. Pavan Gorukanti, Director of Yashoda Hospitals Group.

While explaining the PET/CT Dr. Pavan informed, “Cancer cells require a great deal of sugar, or glucose, to have enough energy to grow. PET scanning utilizes a radioactive molecule that is similar to glucose, called fluorodeoxyglucose (FDG). FDG accumulates within malignant cells because of their high rate of glucose metabolism. Once injected with this agent, the patient is imaged on the whole-body PET scanner to reveal cancer growths which are usually difficult to characterize by conventional CT, X-Ray, or MRI.”

While explaining the PET/CT, Dr. Pavan said, “Cancer cells require a great deal of sugar, or glucose, to have enough energy to grow. PET scanning makes use of fluorodeoxyglucose, a radioactive molecule that is similar to glucose (FDG). Because of their high rate of glucose metabolism, malignant cells accumulate FDG. Following administration of this agent, the patient is imaged on a whole-body PET scanner to reveal cancer growths that are typically difficult to characterize using conventional CT, X-Ray, or MRI.”

The PET/CT scanner at Yashoda Hospitals, Malakpet, combines two state-of-the-art imaging modalities. By monitoring glucose metabolism, PET provides very sensitive information regardless of whether a growth within the body is cancerous or not. Meanwhile, computed tomography (CT) provides detailed information about the location, size, and shape of various lesions. The combined PET/CT scanner merges PET and CT images, providing detailed information about the size and shape of various lesions and accurately distinguishing cancerous lesions from normal structures.